UV exposure not linked to risk for melanoma in skin of color
(HealthDay)—Among people with skin of color, ultraviolet (UV) exposure may not be an important risk factor for melanoma, according to […]
» Read moreHome »
(HealthDay)—From 2001 to 2016, the use of Mohs surgery for melanoma increased more than threefold, according to a study published […] Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome. In this […] A pair of studies led by University of North Carolina Lineberger Comprehensive Cancer Center researchers could aid in improved diagnosis […] In 2015, the United States Food and Drug Administration (FDA) approved the use of talimogene laherparepvec (TVEC) for the treatment […] Adoptive cell transfer (ACT) is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable […] A multi-institutional research team, led by investigators at Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard, […] Melanoma kills more than 1,700 Australians every year, which is more than the national road toll. But the good news […] Australian scientists believe that they have created a blood test that is able to detect melanoma in its early stages, […] Scientists at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to […]
2001 to 2016 saw large increase in Mohs surgery for melanoma
Nuclear medicine imaging monitors effectiveness of therapy for melanoma patients
New studies aim to improve melanoma diagnosis
Modified herpes virus effective against late-stage melanoma
Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
Specific CD8 T cell states may indicate response to immune checkpoint therapy for melanoma
A new blood test could detect early stage melanoma in more than 80% of patients
Australian Scientists Reveal New Blood Test That Can Detect Melanoma
Study finds melanoma biomarkers predicting checkpoint blocker response
